Monday, September 10th 2018
Vaxinano has signed a research contract with a third industrial partner to develop a new veterinary vaccine.
â€œIt's exciting to work with the leaders in the fieldâ€. Thus, Didier Betbeder, founder of Vaxinano, welcomes the new R & D contract signed with a global leader in the veterinary pharmaceutical industry. This new partnership will evaluate Vaxinano's technology with respect to a new vaccine in the veterinary field. â€œVaxinano's business development is progressing as plannedâ€, he explained, and this new partnership consolidates Vaxinanoâ€™s vaccine platform.